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Human erythrocytes that lack the Duffy blood group antigens are refractory to
infection by Plasmodium knowlesi malaria parasites in vitro and Plasmodium vivax in
vivo, suggesting that these antigens are used as ligands for invasion of erythrocytes
by merozoites (1-5). This specificity has been the prototype for understanding malaria
parasite invasion oferythrocytes. The molecule that carries a Duffy determinant was
characterized recently as a 35-45-kD glycoprotein (6), but no parasite molecule with
specificity for Duffy has been described. A study with Plasmodiumfalciparumdemon-
strated that after release of merozoites from cultured schizont-infected erythrocytes,
a 175-kD protein accumulates in the culture supernatant. This molecule binds to
both Duffy-positive and Duffy-negative human erythrocytes that are invaded, but
does not bind to neuraminidase- or trypsin-treated human erythrocytes that are refrac-
tory to invasion by P. falciparum (7). We used modifications of methods of Camus
and Hadley (reference 7, Haynes, J. D., manuscript in preparation) to determine
whether P. knowlesi uses a receptor analogous to that of P. falciparum but with the
appropriate specificity for Duffy blood group antigen . Erythrocytes were incubated
with the metabolically labeled proteins in culture supernatant, centrifuged through
oil, and the bound proteins were eluted with salt. We now describe a 135-kD protein
synthesized by P. knowlesi that bound to Duffy blood group-positive, but not to Duffy
blood group-negative, human erythrocytes. It seems likely that the 135-kD Duffy
binding protein is one of the receptors responsible for invasion ofP. knowlesi merozoites
into Duffy-positive erythrocytes.
Materials and Methods
Parasites andLabeled Culture Supernatants.
￿
Schizont-infected rhesus erythrocytes (Malaysian
H strain of P . knowlesi) were enriched and metabolically labeled at 1.5 x 10'/ml with 100
gCi/ml ["Slmethionine in methionine-deficient RPMI-1640 culture medium (3, 8) with 1%
rabbit serum. The parasites were cultured for 6-10 h to allow the maturation of schizonts,
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the release of merozoites, and the release of molecules from merozoites. There were <100 1o
uninfected erythrocytes in the culture. A control culture of uninfected rhesus erythrocytes
was similarly prepared. Culture supernatant was centrifuged (1,000 g for 15 min, then 10,000
g for20 min) before freezing at -70°C. Culture supernatant ofP. falciparum schizonts(Camp
strain) was obtained after labeling with 50 pCi/ml ['H]isoleucine in medium containing 0.03
mM isoleucine and 10% human serum (7).
Erythrocytes and Pretreatments with Enzymes.
￿
Erythrocytes were collected in acid citrate dex-
trosesolution and stored at 4°C forup to 3 wk. Washed erythrocytes were treated with tosyl-
phenylalanine-chloromethyl-ketone (TPCK)-trypsin or tosyl-lysine-chloromethyl-ketone
(TLCK)-chymotrypsin followed by soybean trypsin inhibitor(STI)or PMSF, (Sigma Chemical
Co., St. Louis, MO), or control treatment with inhibitor alone (6, 7). The treated erythro-
cytes were extensively washed before using in binding and invasion studies.
Du ffy Phenotype Determination.
￿
The Duffy-positive (Fy" and Fyi') and Duffy-negative (FyFy)
phenotypes of untreated human and rabbit erythrocytes were determined by standard blood
banking methods. Duffyphenotypes ofrhesus (Macaca mulatto) andofenzyme-treated erythro-
cytes were determined by the depletion or by the adsorption and elution of Duffy antibodies
(1, 3, 9).
Binding to and Elutionfrom Erythrocytes.
￿
Washed erythrocytes (100 RI) and culture superna-
tant (400 wl) were mixed for 30 min at room temperature. The suspension was layered over
silicone oil (GE Uersilube F50) and centrifuged for 30 s at 13,000 g. The erythrocyte pellet
was washed once with culture medium, mixed with 18 g1 of 1.5 M NaCl, and eluted 10 min
at room temperature, then centrifuged at 13,000 g. For the P . falciparum binding study, 60
ul of erythrocytes were centrifuged through silicone oil but not washed. The supernatant eluate
was heated with an equalvolume of2x SDS sample buffer, electrophoresed on a5-10% linear
gradient polyacrylamide gel(Fig. 1), or a 7.5% gel (Figs. 2, 3, and 5) andprocessedfor auto-
radiography (8). Prestained molecularweight markers(BethesdaResearch Laboratories, Rock-
ville, MD) were electrophoresed on the same gel.
Invasion ofErythrocytes.
￿
The ability of P. knowlesi to invade erythrocytes was examined in
10% FCS containing medium (3, 5) for duplicate cultures with the same erythrocytes used
concurrently in the binding and elution studies.
Competitive Binding ofAnti-Duffy Antibodies and the 135-kD Protein.
￿
The anti-Fy' monoclonal
IgGI antibody (NYBC-BG6) was a gift ofJohn Barnwell (New York University, New York,
NY) and Pablo Rubenstein, (New York Blood Center, New York, NY) (10). The MOPC21
mouse myeloma IgGI control was a gift of Richard Asofsky (National Institutes of Health,
Bethesda, MD). Human Fyb erythrocytes or rhesus erythrocytes (75 ul) were suspended in
120 wl RPMI-1640 medium containing 0.25% wt/vol BSA and either 10 ug anti-Fy' or 10
ug MOPC21 IgGI. After2 h of rockingat room temperature, 400 ul of radiolabeled P. knowlesi
culture supernatant was added and rockingwascontinued another30 min. Theerythrocytes
were washed and eluted, and electrophoresis was carried out as described above. Similar ex-
periments were performed with human Fy" and Fyb erythrocytes and a high titer anti-Fy'
serum (6).
Electroblotting and Probing.
￿
Procedures were modified from reference6. Erythrocyte ghosts
from Fy", Fyb, and FyFy erythrocytes were extracted in an equal volume of 0.06 M Tris (pH
7.5), 0.5 M NaCl, and 0.2 % deoxycholate, and were centrifuged at 10,000 g for 20 min. The
supernatant was added to an equal volume of 2x SDS sample buffer without heating, elec-
trophoresed on 10% polyacrylamide gels, and electrophoretically transferred to nitrocellu-
lose paper. The blots were blocked for 1 h with 0.3% Tween-20 in PBS and another hour
with 1% rabbit serum added. The blots were probed with [''S]methionine-labeled 135-kD
protein eluted from 4 ml of Fyb erythrocytes. The eluate was supplemented with 1° fo rabbit
serum, dialyzed extensively against PBS, and brought to a final volume of 5 ml with PBS
containing 1% rabbit serum. The blots were incubated in this solution for 2 h at room tem-
perature with shaking, rinsed five timeswith cold PBS, dried, andexposed to x-rayfilm. Dupli-
cate blots were reacted with anti-Fy' antibody and visualized using alkaline phospha-
tase-conjugated anti-human IgG (Promega Biotec, Madison, WI).HAYNES ET AL.
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FIGURE 1 .
￿
Metabolically nadiolabeled proteins
from P . knowlesi culture supernatants that bind
to and are eluted from erythrocytes then analyzed
by electrophoresisandautoradiography . Binding
to erythrocytes from three Duffy apeople (lanes
1-3), threeDuffybpeople (lanes 4-6),oneDuffy-
negative rabbit (lane 7), three Duffy-negative
people (lanes 8-10), and one Duffy b rhesus
monkey (lane 11) . The 135-kD protein is indi-
cated by the arrow on the right and molecular
weight markers are indicated on the left.
Results
A 135-kD protein from culturedP . knowlesi bound to and was eluted from Duffy
a (Fya)- or Duffy b (Fyb)-positive human erythrocytes but not Duffy-negative (FyFy)
human erythrocytes (Fig . 1) . The 135-kD protein was a minor fraction of the total
[35S]methionine-radiolabeled molecules in culture supernatants (Fig. 2) . The 135-
kD protein migrated faster than a previously described 140-kD antigen (8) run on
the same gel (not shown) . A minor band of 120 kD was also present . Control
[
35S]methionine-labeled rhesus erythrocyte cultures without the parasite did not
produce significant amounts of radiolabeled culture supernatant proteins, and no
135-kD protein binding to Duffy-positive erythrocytes was detected from such con-
trol cultures (data not shown) .
The 135-kD molecule also bound to rhesus erythrocytes (Fig . 1), which are Fyb
(3). It did not bind to rabbit erythrocytes (Fig . 1) or guinea pig erythrocytes (data
not shown), which areDuffy-negative and arenot invaded by P . knowlesi (3). Rhesus
erythrocytes bound several additional molecules, including a band of>200 kD that
did not bind to rabbit or human erythrocytes (Fig. 1) .
The binding of the 135-kD protein to human Fyb erythrocytes (Fig . 3) was
blocked by an mAb against a newly described Fyb determinant present on human
Duffy-positive erythrocytes (10). Anti-Fy6 antibody did not block the 135-kD pro-
tein binding to rhesus erythrocytes (Fig. 3) that lack the Fy6 determinant (10) . Con-
trols with myelomaantibody ofthe same IgG subtype andwith rhesus erythrocytes
indicated that the antibodies did not interfere nonspecifically with binding . Simi-1876
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Figure 2 .
￿
Comparison of the radiolabeled molecules in total culture superna-
tant (lane 1) and those binding to human Duffy b erythrocytes (lane 2).
larly, specific blocking of binding to Fya erythrocytes but not to Fyb erythrocytes
was seen in experiments with human Fya and Fyb erythrocytes and anti-Fya antisera
(data not shown) .
The 135-kD protein consistently distinguished between Fya and Fyb human
erythrocytes . The quantity of 135-kD protein eluted from Fyb was always greater
than that from Fya (Fig . 1 and data not shown) . Furthermore, when the culture
supernatant was preadsorbed with Fya or Fyb erythrocytes and then assayed for 135-
kD protein binding to rhesus erythrocytes, agreater amounts ofthis 135-kD protein
was depleted by the Fyb erythrocytes (data not shown) . This specificity indicates that
the molecules carrying the Duffy blood group antigens are themselves the ligands
for the binding of the receptor. To show this definitively, the 135-kD protein was
eluted from Fyb erythrocytes and used to probe erythrocyte membrane proteins that
had been electrophoretically separated and transferred to nitrocellulose (Fig. 4) . The
135-kD P knowlesi protein bound to the 35-45-kD region in lanes containing Duffy-
positive erythrocyte proteins, but not to those containing Duffy-negative erythro-
cyte proteins . Again, greater binding was observed to the Fyb antigen than to the
Fya antigen . As a control, parallel lanes probed with an anti-Fya serum demon-
Figure 3 .
￿
Blocking of binding of the 135-kD protein by
competition with anti-Duffy antibody. Erythrocytes were
incubated with anti-Fyb mAb (Fy 6), or control antibody
(C), then incubated with radiolabeled P, knowlesi culture su-
pernatants, washed, and eluted. Duffyb erythrocytes were
human Fyb erythrocytes that also carried the Fyb deter-
minant (10). Rhesus erythrocytes carried the Fyb but lacked
the Fy b determinant (10) . The position of the 135-kD pro-
tein is noted by the arrow.HAYNES ET AL.
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Figure 4.
￿
Binding of the 135-kD protein to Duffy blood
group antigens on blots of electrophoretically separated
erythrocyte membrane proteins . Purified 135-kD protein
wasincubatedwithblotsfrom erythrocytes thatwere Duffy-
negative (lanes 1 and 2), Duffy b (lanes 3and 4), or Duffy
a (lanes 5and6) ; and anti-Duffy aantibody wasincubated
with blotsfrom Duffy-negative (lane 7) or Duffyaerythro-
cytes (lane 8) .
strated, as previously shown (6), that Duffy antigen is carried on a 35-45-kD eryth-
rocyte glycoprotein .
Cleavage of theDuffy antigenon human erythrocytes by chymotrypsin treatment
eliminated binding of the 135-kD molecule to the treated erythrocytes, and the
Figure 5 .
￿
Binding andelution of the P . knowlesi 135-kD protein (solid arrow) or theP . falciparum
175-kD protein (open arrow) to enzyme-treated erythrocytes . (Left) [35Slmethionine-labeled
molecules from P . knowlesi culture supernatant that bound to and eluted from different erythro-
cytes : Duffy b human erythrocytes either untreated (none), treated with 1 mg/ml chymotrypsin,
0.1 mg/mlchymotrypsin (0.1 mg chymo. ), 5 x 10-4MPMSF, or 1 mg/mltrypsin ; Duffy-negative
rabbit erythrocytes ; Duffy-negative human erythrocytes treated with trypsin or with 1 mg/ml
STI; rhesus erythrocytes (Duffy b) either treated with 1 mg/ml chymotrypsin (1 mg chymo.) or
untreated (none). The + or - above a lane indicates the presence or absence of Duffy antigen
(1, 3, 9) . The numbers below the lanes are percentages of erythrocytes invaded by P, knowlesi .
(Right) [3Hlisoleucine-labeled molecules from Pfalciparum culture supernatant that bound to and
eluted from Duffyb humanerythrocytes either untreated (none), treated with 1 mg/mlchymotrypsin
(1 mg chymo. ), 0.1 mg/ml chymotrypsin (0.1 mg chymo . ), PMSF, trypsin, or STI .1878
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chymotrypsin-treated erythrocytes were refractory to invasion by P. knowlesi (Fig.
5 and reference 5). These chymotrypsin-treated erythrocytes were normally invaded
by P. falciparum and still bound the 175-kD receptor from P. falciparum (Fig. 5 and
reference 7). Conversely, trypsin-treated Duffy-positive erythrocytes boundthe receptor
for Duffy from P. knowlesi but not the 175-kD receptor from P. falcifiarum . Trypsin
does not cleave Duffy blood group antigen ; the treated erythrocytes are invaded nor-
mally by P. knowlesi. The invasion ofadditional erythrocytes by P. knowlesi not shown
in Fig.5 are 9.2% for STI-treated Duffy b human, 0.4% for Duffy-negative human,
and 12 .9% for PMSF-treated rhesus erythrocytes. Invasion of treated erythrocytes
by P. falciparum parasites is reduced to 10-25% of control by 1 mg/ml trypsin and
unaffected by 0.1 mg/ml chymotrypsin (5, 11). For each species of parasite, in each
of these instances, invasion paralleled the binding of the respective putative receptor
molecule.
Despite the specificity of the Duffy receptor-ligand interaction, invasion occurs
under unusual circumstances independently ofthis interaction. P. knowlesi merozoites
invade trypsin-treated Duffy-negative human erythrocytes and chymotrypsin-treated
rhesus erythrocytes (3, 5), both of which lack the Duffy antigen and fail to bind
the 135-kD receptor for Duffy (Fig. 5).
Discussion
The correspondence between the binding of the 135-kD P. knowlesi protein and
the invasion of Duffy-positive erythrocytes suggests that the 135-kD P. knowlesi pro-
tein is a receptor for invasion. Whether its binding to a Duffy ligand on a Duffy-
positive erythrocyte prepares the erythrocyte for invasion, acts as an adhesion mole-
cule between the erythrocyte and the merozoite, transmits a signal to the merozoite
activating it for invasion, or initiates some combination of these remains to be deter-
mined. The specificity of the 135-kD putative receptor is emphasized not only by
its lack of binding to Duffy-negative (FyFy) erythrocytes (Figs. 1 and 5), but also
by the consistent demonstration of greater binding to Fyb than to Fya, both to an-
tigen in situ on erythrocytes and electrophorectically separated on blots (Figs. 1 and
4). The fact that experiments to date do not show any great difference in the rate
of invasion of Fya and Fyb erythrocytes may indicate that a threshold binding of
the 135 kd protein less than the possible maximum is sufficient for invasion under
these experimental conditions. Nevertheless, otherwise normal Duffy-negative human
erythrocytes do not bind the 135-kD protein and are not invaded.
Anti-Fya serum blocks invasion of Fya erythrocytes by P. knowlesi (3) and blocks
the binding of the 135-kD protein. Available anti-Fyb antisera were not strong
enough to block invasion or binding, but here we show blocking of the 135-kD pro-
tein binding to Fyb erythrocytes by an anti-Fy6 mAb that reacts with a newly de-
scribed Duffy Fyb determinant that is independent of Fya and Fyb (Fig. 3 and ref-
erence 10).
It is unlikely that the binding of the 135-kD protein to a Duffy determinant on
the erythrocyte participates in the initial attachment of the P. knowlesi merozoite to
the erythrocyte. The initial attachment occurs with Duffy-negative (FyFy) human
erythrocytes; however, the initial attachmentdoes not progress to the apicaljunction
formation that is seen when the erythrocyte is Duffy-positive (12) .
It is not known why the 135-kD protein is found in the culture supernatant after
merozoite release from infected erythrocytes. The 135-kD putative receptor mayHAYNES ET AL.
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be a secreted molecule or it may dissociate from the merozoite surface. In either
case, the 135-kD protein is only a small fraction ofthe total labeled parasite proteins
released into the culture media, and the selectivity of its binding to erythrocytes
is remarkable (Fig. 2).
Duffy-positive erythrocytes that have been altered by pretreatment with
chymotrypsin or trypsin are differentially invaded by P. knowlesi and P . falciparum
(11). Here we demonstrated that cleavage of the Duffy antigen by chymotrypsin
prevented binding ofthe 135-kD protein ofP. knowlesi, aswell as prevented invasion
by P. knowlesi (Fig. 5). On the other hand, cleavage of glycophorins by trypsin did
not prevent binding ofthe 135-kD protein, nor did it prevent invasion by P. knowlesi.
As additional controls, it was shown that the chymotrypsin treatment did not
nonspecifically prevent binding; the 175-kD putative receptor of P . falciparum still
bound and its merozoites still invaded chymotrypsin-treated erythrocytes. Conversely,
trypsin treatment prevented the binding of the 175-kD putative receptor of P . fal-
ciparum. We conclude that chymotrypsin or trypsin treatment of human erythro-
cytes differentially alters ligands recognized by the two putative receptors. This is
another example ofthe correspondence of binding ofthe 135-kD protein and inva-
sion by P . knowlesi.
However, there are two examples of altered erythrocytes that are invaded by P.
knowlesi that do not bind the 135-kD protein. First, human Duffy-negative (FyFy)
erythrocytesthat have been treatedwith trypsin still do notbind the 135-kD protein
buthave gained some susceptibilityto invasion (Fig. 5). Second, rhesus erythrocytes
that have been treated with chymotrypsin can still be invaded, although they be-
come Duffy-negative and no longer bind the 135-kD protein (Fig. 5). Such enzyme
treatments may expose cryptic non-Duffy ligands, allowing invasion to bypass the
normal sequence requiring binding ofthe 135-kD protein, or allowing invasion to
proceed by an alternative pathway.
In a somewhat similar observation, cleavage ofsialic acid from erythrocytes pre-
vents invasion by many strains ofP .falciparum, but some strains ofP.falciparum para-
sites can invade sialic acid-deficient erythrocytes (5, 13, 14), though they possess
a 175-kD receptor with the usual requirement for a sialic acid-dependent ligand
on the erythrocytes (Hadley, T. J., et al., unpublished data). Thus, it appears that
malaria parasites can bypass certain steps or use alternative pathways for invasion.
Analogies to the serum complement cascades may be valid. Alternative pathways
may be used by theparasite to invade different host erythrocytes andtobe available
as a backup system for invasion if the host's antibodies should interfere with one
or the other. Other possible receptors for invasion have been reviewed (5) and in-
clude a 66-/44-/42-kD P. knowlesi merozoite surface protein (15).
The fact that the parasite can invade some altered erythrocytes without the inter-
action ofthis putative receptor (the 135-kD protein) and ligand (the Duffy antigen)
probably reflects the selective advantage that alternative mechanisms for invasion
impart to the parasite. Thus, in designing an antimalarial vaccine directed against
receptors used forinvasion itwould be desirable toinclude several receptor proteins.
Summary
A 135-kD parasite protein, a minor component ofthe Plasmodium knowlesi malaria
radiolabeled proteins released into culture supernatant at the time ofmerozoite re-
lease and reinvasion, specificallybound to human erythrocytesthat are invaded and1880
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carry a Duffy blood group determinant (Fya or Fyb), but did not bind to human
erythrocytes that are not invaded and do not carry a Duffy determinant (FyFy). Specific
anti-Duffy antibodies blocked the binding ofthe 135-kD protein to erythrocytes car-
rying that specific Duffy determinant. Purified 135-kD protein bound specifically
to the 35-45-kD Duffy glycoprotein on a blot ofelectrophoretically separated mem-
brane proteins from Fya and Fyb erythrocytes but not from FyFy erythrocytes.
Binding of the 135-kD protein was consistently greater to Fyb than to Fya both on
the blot and on intact erythrocytes. The 135-kD protein also bound to rhesus erythro-
cytes that are Fyb and are invaded, but not to rabbit or guinea pig erythrocytes that
are Duffy-negative. and are not invaded. Cleavage of the Duffy determinant by
pretreating Fyb human erythrocytes with chymotrypsin greatly reduced both inva-
sion and binding of the 135-kD protein, whereas pretreating Fyb erythrocytes with
trypsin had little effect on the Duffy antigen,the 135-kD protein binding, or on inva-
sion. However, instances of invasion of other enzyme-treated erythrocytes that are
Duffy-negative and do not bind the 135-kD protein suggest that alternative pathways
for invasion do exist.
We thank J. Chulay, M. Zegans, K. Pinkston, D. Camus, L. Reyes, C . Diggs, M. Mallet,
D. Finbloom, G. Schatz, and I. Green for helpful discussions and support. The views of the
authors do not purport to reflect the position of the United States Army or the Department
of Defense.
Receivedfor publication 29 October 1987 and in revisedform 29 February 1988.
References
1 . Miller, L. H., S. J. Mason, J. A. Dvorak, M. H. McGinniss, and I. K. Rothman . 1975.
Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants.
Science (Wash. DC). 189:561.
2 . Miller, L. H., S. J. Mason, D. F. Clyde, and M . H. McGinniss. 1976. The resistance
factor to Plasmodium vivax in blacks. The Duffy blood group genotype FyFy. N. Engl.
f. Med. 295 :302.
3 . Mason, S. J ., L. H. Miller, T. Shiroishi, J. A. Dvorak, and M. H. McGinniss. 1977.
The Duffy blood group determinants: their role in the susceptibility of human and an-
imal erythrocytes to Plasmodium knowlesi malaria. Br. .J. Haematol. 36:327.
4. Miller, L. H., M. H. McGinniss, P. V. Holland, and P Sigmon. 1978. The Duffy blood
group phenotype in American blacks with Plasmodium vivax in Vietnam. Am.f. Trop. Med.
Hyg. 27 :1069.
5. Hadley, T. J., F. W. Klotz, and L. H. Miller. 1986. Invasion of erythrocytes by malaria
parasites: a cellular and molecular overview. Annu. Rev. Microbiol. 40:451.
6. Hadley, T. J., P. H . David, M. H. McGinniss, and L. H. Miller. 1984. Identification
of an erythrocyte component carrying the Duffy blood group Fy'' antigen. Science (Wash.
DC. 223:597 .
7 . Camus, D., and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host
erythrocytes and merozoites. Science (Wash.DC). 230:553.
8. Miller, L. H ., P. H. David, D. E. Hudson, T. J. Hadley, R. L. Richards, and M. Aikawa.
1984. Monoclonal antibodies to a 140,000-M.W. protein on Plasmodium knowlesi merozoites
inhibit their invasion of Rhesus erythrocytes. .J. Immunol. 132 :438.
9. Hadley, T. J., M. H. McGinniss, F. W. Klotz, and L. H . Miller. 1986. Blood group
antigens and invasion of erythrocytes by malaria parasites. In Red Cell Antigens andHAYNES ET AL.
￿
1881
Antibodies. G. Garratty, editor. American Association of Blood Banks, Arlington, VA.
17-33.
10. Nichols, M. E., P. Rubinstein, J. Barnwell, S. R. DeCordoba, and R. E. Rosenfield.
1987 . A new human Duffy blood group specificity defined by a murine monoclonal anti-
body. J Exp. Med. 166 :776.
11 . Miller, L. H., J . D. Haynes, F. M. McAuliffe, T. Shiroishi, J. R. Durocher, and M . H.
McGinniss. 1977 . Evidence for differences in erythrocyte surface receptors for the malarial
parasites, Plasmodium falciparum and Plasmodium knowlesi. J Exp. Med. 146:277 .
12. Miller, L. H., M. Aikawa, J. G. Johnson, and T. Shiroishi. 1979. Interactions between
cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction for-
mation. J. Exp. Med. 149:172.
13. Mitchell, G. H., T. J. Hadley, F. W. Klotz, M . H. McGinniss, and L. H. Miller. 1986.
Invasion oferythrocytes by Plasmodiumfalciparum malaria parasites: evidence for receptor
heterogeneity and two receptors. Blood. 67:1519.
14. Hadley, T. J., F. W. Klotz, G. Pasvol, J. D. Haynes, M. H. McGinnis, Y. Okubo, and
L. H. Miller. 1987. Falciparum malaria parasites invade erythrocytes that lack glycophorin
A and B (MkMk): strain differences indicate receptor heterogeneity and two pathways
for invasion . J. Clin. Invest. 80:1190.
15. Thomas, A.W., J. A. Deans, G. H. Mitchell, T. Alderson, and S. Cohen. 1984. The Fab
fragments ofmonoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi inva-
sion of erythrocytes. Mol. Biochem. Parasitol. 13:187.